ACA	Affordable Care Act
ACIP	Advisory Committee on Immunization Practices
AE	Adverse effect
AEFI	Adverse effect following immunization
ASCO	American Society of Clinical Oncology
CDC	Centers for Disease Control and Prevention
CI	Confidence interval
COVID-19	Coronavirus disease 2019
FDA	Food and Drug Administration
HSCT	Hematopoietic stem-cell transplantation
HZ	Herpes zoster
HZO	Herpes zoster ophthalmicus
IC	Immunocompromised
JCVI	Joint Committee on Vaccination and Immunisation
IR	Incidence rate
MPL	3-O-desacyl-4′-monophosphoryl lipid A
Non-IC	Non-immunocompromised
PHN	Postherpetic neuralgia
PY	Person-years
RZV	Recombinant zoster vaccine
TLR4	Toll-like receptor type 4
VAERS	Vaccine Adverse Event Reporting System
VE	Vaccine effectiveness
VZV	Varicella–zoster virus
ZVL	Zoster vaccine live